Risikostratifizierung durch Implementierung und Evaluation eines COVID-19-Scores

Hüfner, Andreas; Kiefl, Daniel; Baacke, Markus; Zöllner, Rebecca; Mencía, Eneldo Loza; Schellein, O.; Avan, N; Pemmerl, Sylvia

doi:10.1007/s00063-020-00754-4

Cited by 8 publications

(2 citation statements)

References 5 publications

(4 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pulse oximeter [12] Beurer PO 60 pulse oximeter, Beurer The medical history questionnaire included questions on current COVID-19 symptoms, relevant pre-existing medical conditions and current medication. Overall, the medical history questionnaire consisted of 35 questions requiring yes or no answers (see supplementary material table S.2) and was developed on the basis of available publications [16][17][18][19]. As the pandemic was evolving rapidly and studies in an ambulatory setting were urgently needed, the first patients were included while the questionnaire was still under development.…”

Section: Device Image Modelmentioning

confidence: 99%

Implementing remote monitoring for COVID-19 patients in primary care

Holtz,

Köhler,

Chabiera

et al. 2024

Preprint

View full text Add to dashboard Cite

Background In Germany, most patients with coronavirus disease 2019 (COVID-19) are treated in an outpatient setting. To improve assessments of the health status of COVID-19 outpatients, various remote monitoring models have been developed. However, little information exists on experiences acquired with remote monitoring in an outpatient setting, particularly from a patient perspective. The aim of our 'COVID-19@home' study was therefore to implement and evaluate an app-based remote monitoring concept for acute and post-acute COVID-19-patients in primary care. In this paper, we focus on the patients' evaluation of our remote monitoring approach. Methods Patients with acute COVID-19 measured heart rate, blood pressure, oxygen saturation, and body temperature daily for 28 days. Patients with post-acute COVID-19 determined the same parameters for 12 weeks, supplemented by lung parameters and daily step count. The data were documented using the 'SaniQ' smartphone app. COVID-19 symptoms were assessed daily using an app-based questionnaire. Patients' GPs could access the data on the 'SaniQ Praxis' telemedicine platform. We used an app-based questionnaire consisting of 11 questions presented with a 4-point Likert scale to evaluate patient satisfaction. Data were analyzed descriptively. Results Of the 51 patients aged 19-77 years that participated in the study, 42 completed the questionnaire. All patients rated home monitoring as 'very good' or 'rather good' and were able to integrate the measuring processes into their daily routines. Overall, 93% would recommend the app and the measuring devices to their family and friends. About 60% felt that their COVID-19 treatment had benefited from home monitoring. Only few patients were unsettled by the app and use of the measuring devices. During the course of the study, the implementation process was optimized. Conclusions The use of remote monitoring in COVID-19 patients is feasible and was evaluated positively by most study patients. However, it is difficult to imagine how general practices could cope with monitoring patients with acute diseases without any further organizational support. Future research should address cost-effectiveness and changes in such clinical outcomes as hospitalization and mortality.

show abstract

Section: Device Image Modelmentioning

confidence: 99%

Implementing remote monitoring for COVID-19 patients in primary care

Holtz,

Köhler,

Chabiera

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…The following supporting information can be downloaded at: . These references [ 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 ] have been referred to in supplementary materials. Online Supplement.…”

mentioning

confidence: 99%

Cost–Benefit of Real-Time Multiplex PCR Testing of SARS-CoV-2 in German Hospitals

Diel

Nienhaus

2023

IJERPH

View full text Add to dashboard Cite

Background: The current Omicron COVID-19 pandemic has significant morbidity worldwide. Objective: Assess the cost–benefit relation of implementing PCR point-of-care (POCT) COVID-19 testing in the emergency rooms (ERs) of German hospitals and in the case of inpatient admission due to other acute illnesses. Methods: A deterministic decision-analytic model simulated the incremental costs of using the Savanna® Multiplex RT-PCR test compared to using clinical judgement alone to confirm or exclude COVID-19 in adult patients in German ERs prior to hospitalization or just prior to discharge. Direct and indirect costs were evaluated from the hospital perspective. Nasal or nasopharyngeal swabs of patients suspected to have COVID-19 by clinical judgement, but without POCT, were sent to external labs for RT-PCR testing. Results: In probabilistic sensitivity analysis, assuming a COVID-19 prevalence ranging between 15.6–41.2% and a hospitalization rate between 4.3–64.3%, implementing the Savanna® test saved, on average, €107 as compared to applying the clinical-judgement-only strategy. A revenue loss of €735 can be avoided when SARS-CoV-2 infection in patients coming unplanned to the hospital due to other acute illnesses are excluded immediately by POCT. Conclusions: Using highly sensitive and specific PCR-POCT in patients suspected of COVID-19 infection at German ERs may significantly reduce hospital expenditures.

show abstract